Gekkowolf, if you had even the slightest idea about Cafa's and Whyee's knowledge about treating cancers with localised radioactive treatments, the process to have medical devices approved and the requirements for marketing such devices, you'd STFU and read their multi-year posts in the SRX thread. Then you'd beg for their OSL insights.
How anyone can ignore $48m of accumulated losses, 10+ years of trading with limited success in advancing industry acceptance of the device, 5+ years of embarrassing "any minute now" announcements by management - and still blame those "dastardly down-rampers" for the woes of the company and its SP is - I was going to say staggering - but its just plain dumb.
OSL Price at posting:
7.3¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)